Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02879162
Brief Title: Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours

First Submitted : August 22, 2016
First Submitted that Met QC Criteria : August 22, 2016
First Posted : August 25, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 17, 2020
Last Update Posted : September 18, 2020